Weigao Holding Co., Ltd. is located in the beautiful coastal city of Weihai. The group has 43 subsidiaries and branches, and has formed a development pattern in which the five major business areas of medical equipment, pharmaceuticals, military industry, real estate, and investment are advancing hand in hand. Among them - Shandong Weigao Group Medical Polymer Products Co., Ltd. is a Hong Kong listed company. The group has total assets of 3.5 billion yuan and 7,600 employees, including 873 with intermediate and senior professional and technical titles. The factory covers an area of ??1.2 million square meters and has a purification workshop of 160,000 square meters that meets GMP requirements and can produce more than 190 There are nearly 7,000 varieties of medical devices, drugs and sanitary materials in more than one specification. The company adheres to the factory building policy of "exploitation, innovation, truth-seeking and consolidation", adheres to the development of new medical device products with high technology content and high added value, focuses on improving product quality, and strengthens corporate management based on scientific management. Model, adhering to the people-oriented, technology-first development strategy, promotes the sustainable, rapid and healthy development of the enterprise. The company was the first in the industry to introduce advanced management models such as ERP, JIT, KPI, and CRM, and has passed quality system certifications such as ISO9001 certification, EU CE certification, China CMD certification, and China 3C certification. Some products have passed the U.S. FDA registration. The company's testing center has been accredited by the National Laboratory Accreditation Board, and the test reports issued have legal effect. The company has been designated by the Ministry of Science and Technology as the "Industrial Transformation Base of National High-tech Research and Development (863) Program Achievements" and the "Key High-tech Enterprise of the National Torch Plan". It has established a postdoctoral workstation and is in cooperation with some science and technology institutes across the country that have strong scientific and technological research and development capabilities. Institutes of research and universities have jointly established five R&D centers named after Weigao Group, creating a development path integrating production, learning and research, improving R&D and innovation capabilities, and currently has more than 150 patented products. The company has successively undertaken 12 national-level projects, including 2 "863" scientific research projects and 3 Torch Plan projects. The company has established more than 100 sales offices in 30 provinces, municipalities and autonomous regions across the country. It has established long-term and stable relationships with more than 4,000 hospitals, more than 400 blood stations, and more than 1,800 commercial companies across the country. The "Jierui" brand was awarded "China's Well-known Trademark" and became the first well-known trademark in China's medical device industry. "Jierui" brand disposable sterile infusion medical devices were awarded the title of "China Famous Brand Product". Products are directly supplied to more than 60 countries and regions including the United States, the European Union, Russia, South Africa, and Brazil. In recent years, the Group has adhered to the business philosophy of "exploitation, innovation, truth-seeking and consolidation" and focused on human resource construction, vigorously promoting the adjustment of industrial structure, product structure, and institutional structure, and consolidating and developing its market position in the medical device and pharmaceutical industries. At the same time, it has made strides into military industry, real estate, financial investment and other industries, and achieved outstanding results, laying a solid foundation for the group to develop into a first-class domestic comprehensive enterprise group.

Reference materials: 1./group/cn/weigaogroup.aspx